Celldex Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Revenue	5.79	7.02	6.88	2.36	4.65	7.42	Upgrade
Revenue Growth (YoY)	-30.25%	1.99%	192.02%	-49.32%	-37.30%	107.61%	Upgrade
Gross Profit	5.79	7.02	6.88	2.36	4.65	7.42	Upgrade
Selling, General & Admin	41.53	38.55	30.91	27.2	20.49	14.46	Upgrade
Research & Development	199.01	163.55	118.01	82.26	53.31	42.53	Upgrade
Other Operating Expenses	-	-	12.5	8.14	2.1	13.78	Upgrade
Total Operating Expenses	240.54	202.1	161.43	117.59	75.89	70.77	Upgrade
Operating Income	-234.75	-195.08	-154.54	-115.23	-71.24	-63.35	Upgrade
Interest Income	35.14	37.22	13.11	2.91	0.51	2.41	Upgrade
Total Non-Operating Income (Expense)	35.14	37.22	13.11	2.91	0.51	2.41	Upgrade
Pretax Income	-199.61	-157.86	-141.43	-112.33	-70.74	-60.95	Upgrade
Provision for Income Taxes	-	-	-	-	-0.23	-1.17	Upgrade
Net Income	-199.61	-157.86	-141.43	-112.33	-70.51	-59.78	Upgrade
Net Income to Common	-199.61	-157.86	-141.43	-112.33	-70.51	-59.78	Upgrade
Shares Outstanding (Basic)	66	64	48	47	43	30	Upgrade
Shares Outstanding (Diluted)	66	64	48	47	43	30	Upgrade
Shares Change (YoY)	18.38%	32.91%	3.33%	9.37%	44.64%	104.31%	Upgrade
EPS (Basic)	-3.01	-2.45	-2.92	-2.40	-1.64	-2.02	Upgrade
EPS (Diluted)	-3.01	-2.45	-2.92	-2.40	-1.64	-2.02	Upgrade
Free Cash Flow	-188.48	-159.7	-109.11	-105.56	-62.16	-41.96	Upgrade
Free Cash Flow Per Share	-2.84	-2.48	-2.25	-2.25	-1.45	-1.42	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-4053.69%	-2778.89%	-2245.27%	-4889.01%	-1531.78%	-854.06%	Upgrade
Profit Margin	-3446.88%	-2248.76%	-2054.76%	-4765.59%	-1516.04%	-805.88%	Upgrade
FCF Margin	-3254.77%	-2274.89%	-1585.20%	-4478.57%	-1336.44%	-565.60%	Upgrade
EBITDA	-231.4	-191.9	-151.53	-112.34	-68.18	-59.43	Upgrade
EBITDA Margin	-3995.92%	-2733.63%	-2201.57%	-4766.14%	-1465.81%	-801.09%	Upgrade
EBIT	-234.75	-195.08	-154.54	-115.23	-71.24	-63.35	Upgrade
EBIT Margin	-4053.69%	-2778.89%	-2245.27%	-4889.01%	-1531.78%	-854.06%	Upgrade
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.32%	1.91%	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q